-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shisi Pharmaceutical Donates RMB 150,000 Worth of Emergency Medicines to the Shennongjia Forestry District
Category:
发布时间：2020-02-15
【概要描述】
On the afternoon of February 14, Shijiazhuang Sihua Pharmaceutical Co., Ltd. loaded and dispatched a donation of RMB 150,000 worth of moxifloxacin hydrochloride sodium chloride injection to the Shennongjia Forestry District in Hubei Province, which is receiving counterpart support from Hebei Province.
On the afternoon of February 14, Shijiazhuang Sihua Pharmaceutical Co., Ltd. loaded and dispatched a shipment of RMB 150,000 worth of moxifloxacin hydrochloride sodium chloride injection to the Shennongjia Forestry District in Hubei Province, which is receiving counterpart support from Hebei Province. This marks the second batch of emergency relief medicines donated by Sihua Pharmaceutical to Hubei, following its earlier donation on January 25—the first day of the Lunar New Year—of RMB 2 million worth of moxifloxacin hydrochloride sodium chloride injection to designated hospitals in Wuhan that are treating COVID-19 patients.
On the evening of February 12, Shisi Pharmaceutical received a letter from the Hebei Provincial Federation of Industry and Commerce forwarding a request from the Shennongjia Forestry District Federation of Industry and Commerce in Hubei Province for support in the form of COVID-19 epidemic prevention and control supplies. Upon learning of the situation, Su Xuejun, Vice President of the Hebei Provincial General Chamber of Commerce and Chairman of Shisi Pharmaceutical, immediately coordinated with both the Hebei Provincial Federation of Industry and Commerce and the Shennongjia Forestry District Federation of Industry and Commerce to ascertain the specific needs.
▲On the afternoon of February 14, Shijiazhuang Sihua Pharmaceutical donated RMB 150,000 worth of moxifloxacin hydrochloride and sodium chloride injection to the Shennongjia Forestry District in Hubei Province as part of Hebei’s paired assistance program; the shipment was loaded and dispatched.
Upon learning of the shortage of emergency medicines at the designated hospital in the forest area, he personally coordinated the allocation of 150,000 yuan worth of moxifloxacin hydrochloride and sodium chloride injection from the reserve stock for donation to the Shennongjia Forest Area, and also arranged for the donation of 2,000 boxes of arbidol capsules to the Provincial Federation of Industry and Commerce’s Provincial Zhongji Poverty Alleviation Foundation for distribution to the forest area.
To ensure that the emergency medicines are delivered to the forest area as soon as possible, thereby gaining valuable time for the treatment of the sick, Shisi Pharmaceutical has also coordinated extensively with specialized courier services to arrange dedicated transportation for this batch of donated relief medications. “Because the donated medicines are urgently needed injectable products in the forest area and cannot be transported via air express, nor can they be delivered directly to the region by most logistics providers, after extensive outreach, the Shijiazhuang Branch of China Post Express Logistics Co., Ltd. agreed to our request and pledged to transport this donation free of charge,” said Li Ligong, Manager of the Storage and Transportation Department at Shisi Pharmaceutical, who is responsible for coordinating logistics support.
According to available information, in order to resolutely implement the decisions and arrangements of the Party Central Committee and the State Council and to provide all-out support for Hubei Province’s COVID-19 prevention and control efforts, the National Health Commission has pooled high-quality resources to establish an inter-provincial pairing-assistance mechanism for medical treatment of COVID-19 cases in Hubei’s cities and prefectures outside Wuhan. Under this mechanism, 19 provinces have been coordinated to provide targeted assistance to 16 cities, prefectures, and county-level cities in Hubei, excluding Wuhan; among them, Hebei Province is providing assistance to the Shennongjia Forestry District.
According to the introduction, the moxifloxacin hydrochloride and sodium chloride injection donated this time is a newly developed broad-spectrum quinolone antibacterial agent by Shisi Pharmaceutical, primarily used for emergency clinical treatment in hospital respiratory departments.
Su Xuejun stated, “Supporting epidemic prevention and control is a corporate social responsibility. Moving forward, we will continue to align precisely with clinical needs, further strengthen the supply and donation of emergency medicines, and make our due contribution to achieving a comprehensive victory in the battle against the epidemic.”
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091